Workflow
Integra (IART) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
英特格拉生命科学英特格拉生命科学(US:IART) ZACKS·2025-10-30 22:35

Integra LifeSciences (IART) reported 402.06millioninrevenueforthequarterendedSeptember2025,representingayear−over−yearincreaseof5.6402.06 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 5.6%. EPS of 0.54 for the same period compares to 0.41ayearago.ThereportedrevenuecomparestotheZacksConsensusEstimateof0.41 a year ago.The reported revenue compares to the Zacks Consensus Estimate of 414.8 million, representing a surprise of -3.07%. The company delivered an EPS surprise of +25.58%, with the consensus EPS estimate being $0.43.While investors closely watch year-over-year changes in headline numbers -- revenue and ea ...